Pre-market hot trades in US stocks: Wah Fu Edu pre-market down 7.69%; Uber Tech pre-market down 3.10%

Tracking Unusual Activity
2025.09.17 13:02
portai
I'm PortAI, I can summarize articles.

Wah Fu Edu pre-market down 7.69%; Uber Tech pre-market down 3.10%; SciSparc pre-market up 115.22%; CDT Equity pre-market up 58.77%; Vyome pre-market up 56.16%

Pre-market Hot Trades in US Stocks

Uber is down 3.10% in pre-market trading. According to recent key news:

  1. On September 17, Uber CEO Dara Khosrowshahi sold 300,000 shares of the company’s common stock, totaling $28,610,676. This news raised concerns about confidence in the company's leadership, leading to a drop in stock price.

  2. On September 17, Uber launched the Uber Safari service, offering adventure tourism services to Nairobi National Park in Kenya. Although this new service is expected to increase revenue, the market response has been lukewarm, failing to boost the stock price.

  3. On September 16, Uber's core business segments—mobility and delivery—continued to expand, with management's guidance indicating sustained growth prospects. However, concerns about its high valuation remain, leading to stock price volatility. The expansion of tourism and logistics platforms is beneficial for Uber.

Top Gainers in Pre-market US Stocks

SciSparc is up 115.22% in pre-market trading. According to recent key news:

  1. On September 17, AutoMax Motors filed a motion with the Jerusalem District Court to suspend the merger process with SciSparc. The court approved this motion due to uncertainties regarding AutoMax Motors' fulfillment of merger conditions. This news caused SciSparc's stock price to surge in pre-market trading.

  2. On September 16, SciSparc announced that AutoMax Motors submitted a motion to the court regarding the approval of the merger agreement, and the court decided to suspend the process until September 30, 2025. This news propelled SciSparc's stock price up 89.13% in after-hours trading.

  3. On September 17, SciSparc's stock price reached approximately $4.25 in pre-market trading, a significant increase from the previous trading day's closing price of $1.84. The trading volume exceeded 21 million shares, far above the three-month average daily trading volume of about 702,000 shares. Industry trends and macro dynamics have a significant impact.

Vyome is up 56.16% in pre-market trading. According to recent key news:

  1. On September 17, Vyome Holdings Inc. released its latest business update, announcing significant progress in clinical trials for its new drug. This news greatly boosted market confidence, leading to a substantial increase in stock price.

  2. On September 16, Vyome Holdings Inc. received an important patent grant, which will help the company maintain a competitive advantage in the coming years. The acquisition of the patent further enhanced investors' confidence in the company's future development.

  3. On September 15, Vyome Holdings Inc. announced a strategic partnership with a large pharmaceutical company, which is expected to significantly enhance the company's market share and profitability. The establishment of the partnership agreement led to a rapid rise in stock price in the short term The pharmaceutical industry has shown strong performance recently, with significant capital inflows